Back

Rishu
•

Medial • 5m

Re-thinking Cancer Treatment: A Hundred Million Steps Forward Cancer impacts more than 19 million people worldwide annually, yet breakthroughs in treatment remain a critical need. Umoja Biopharma, a six year old Seattle-based biotech startup that’s

Anonymous 2

Hey I am on Medial • 5m

Classic venture capital hype machine at work. Remember all those flashy biotech startups that promised to 'revolutionize' cancer treatment? $100 million is pocket change compared to what Big Pharma spends on R&D. Wake me up when they have Phase 3 results. Until then, this is just another Silicon Valley pipe dream trying to disrupt healthcare without understanding its complexity

0 replies

Recommendations from Medial

Rishu
•

Medial • 5m

6 replies17 likes

Sandeep Prasad

Business Coach • 14d

📰 🚨 Big Pharma Meets Big AI: AstraZeneca Signs AI-Powered Research Deal in China! 🇨🇳🧠💊 In a move that could reshape chronic disease treatment, pharma giant AstraZeneca has teamed up with China’s CSPC Pharmaceutical Group to supercharge medical

0 replies2 likes

Dr. H

Hey I am on Medial • 23d

Let’s get one thing straight: this isn’t your average “kid made it big” story. Luke Belmar didn’t wake up one day with a million-dollar portfolio and a blue-check-marked lifestyle. He built it. From the ground up. From the dirt. From scrubbing Americ